tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Polymyositis D017285 1 associated lipids
Scorpion Stings D065008 1 associated lipids
Rotavirus Infections D012400 1 associated lipids
Netherton Syndrome D056770 1 associated lipids
Pseudohypoaldosteronism D011546 1 associated lipids
Dendritic Cell Sarcoma, Interdigitating D054739 1 associated lipids
Intussusception D007443 1 associated lipids
Thrombotic Microangiopathies D057049 1 associated lipids
Autoimmune Diseases of the Nervous System D020274 1 associated lipids
Lupus Erythematosus, Discoid D008179 1 associated lipids
Lymphocytic Choriomeningitis D008216 1 associated lipids
Erythroplasia D004919 1 associated lipids
Hepatic Veno-Occlusive Disease D006504 1 associated lipids
West Nile Fever D014901 1 associated lipids
Hypoalbuminemia D034141 1 associated lipids
Arm Injuries D001134 1 associated lipids
Primary Graft Dysfunction D055031 1 associated lipids
Esophageal Perforation D004939 1 associated lipids
Epididymitis D004823 1 associated lipids
Pruritus Vulvae D011539 1 associated lipids
Central Serous Chorioretinopathy D056833 1 associated lipids
Feline Acquired Immunodeficiency Syndrome D016181 1 associated lipids
Budd-Chiari Syndrome D006502 1 associated lipids
AIDS-Associated Nephropathy D016263 1 associated lipids
Oral Ulcer D019226 1 associated lipids
Epidermolysis Bullosa Dystrophica D016108 1 associated lipids
Lentigo D007911 1 associated lipids
Mutism D009155 1 associated lipids
Amyloid Neuropathies D017772 1 associated lipids
Cervical Intraepithelial Neoplasia D018290 1 associated lipids
Migraine with Aura D020325 1 associated lipids
Porokeratosis D017499 1 associated lipids
Immunoblastic Lymphadenopathy D007119 2 associated lipids
Churg-Strauss Syndrome D015267 2 associated lipids
Mediastinitis D008480 2 associated lipids
Mucinoses D017520 2 associated lipids
Ocular Motility Disorders D015835 2 associated lipids
Oliguria D009846 2 associated lipids
Hutchinson's Melanotic Freckle D018327 2 associated lipids
Fibroadenoma D018226 2 associated lipids
Pityriasis Lichenoides D017514 2 associated lipids
Intracranial Thrombosis D020767 2 associated lipids
Labyrinthitis D007762 2 associated lipids
Paraproteinemias D010265 2 associated lipids
Amputation, Traumatic D000673 2 associated lipids
Anemia, Refractory, with Excess of Blasts D000754 2 associated lipids
Carcinoma, Merkel Cell D015266 2 associated lipids
Fungemia D016469 2 associated lipids
Neuromyelitis Optica D009471 2 associated lipids
Pharyngitis D010612 2 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Summaries for patients. Multitarget therapy for induction treatment of lupus nephritis. 2015 Ann. Intern. Med. pmid:25383607
Plock JA et al. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation. 2015 Transplantation pmid:26102613
TuÄŸcu M et al. Tacrolimus-Induced Diabetic Ketoacidosis and Effect of Switching to Everolimus: A Case Report. 2015 Transplant. Proc. pmid:26093759
Carenco C et al. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors. 2015 Liver Int. pmid:25488375
Yano S et al. Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation. 2015 Ann. Hematol. pmid:25325985
Garcia C et al. Collaborative Brazilian Pediatric Renal Transplant Registry (CoBrazPed-RTx): A Report From 2004 to 2013. 2015 Transplant. Proc. pmid:26036492
Melo MJ et al. Impact of conversion from Advagraf to twice-daily generic tacrolimus in kidney transplant recipients: a single-center study. 2015 Transplant. Proc. pmid:26036484
Santos T et al. New Recipes With Known Ingredients: Combined Therapy of Everolimus and Low-dose Tacrolimus in De Novo Renal Allograft Recipients. 2015 Transplant. Proc. pmid:26036483
Liu Z et al. Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. 2015 Ann. Intern. Med. pmid:25383558
Bifano M et al. An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects. 2015 Clin Drug Investig pmid:25896946
Caro J et al. Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus. 2015 Nephrol. Dial. Transplant. pmid:25274748
Wang L et al. Benefits of minimizing immunosuppressive dosage according to cytochrome P450 3A5 genotype in liver transplant patients: findings from a single-center study. 2015 Genet. Mol. Res. pmid:25966085
Colak H et al. Relationship of Interleukin-10 and Transforming Growth Factor-β Levels With Short-Term Graft Function After Kidney Transplantation. 2015 Transplant. Proc. pmid:25964218
Kim YT et al. Co-treatment effect of pulsed electromagnetic field (PEMF) with human dental pulp stromal cells and FK506 on the regeneration of crush injured rat sciatic nerve. 2015 Int. J. Neurosci. pmid:25271799
Kogiso T et al. Mycophenolate mofetil may induce prolonged severe anemia during pegylated-interferon/ribavirin/simeprevir therapy in liver transplant recipients. 2015 Clin J Gastroenterol pmid:25963122
Tabchi S et al. Successful treatment of Evans syndrome with Tacrolimus. 2015 Invest New Drugs pmid:25209619
Papadopoulos-Köhn A et al. Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant. 2015 Transplantation pmid:25208324
Bae JM et al. Combination therapy with 308-nm excimer laser, topical tacrolimus, and short-term systemic corticosteroids for segmental vitiligo: A retrospective study of 159 patients. 2015 J. Am. Acad. Dermatol. pmid:25956660
Weisenseel P and Reich K [Inverse psoriasis]. 2015 Hautarzt pmid:25896586
Ennaifer R et al. Nodular hyperplasia of the gastrointestinal tract after liver transplantation: role of immunosuppressive therapy? A case report. 2015 Transplant. Proc. pmid:25891739
Chen KH et al. De novo cancer avoidance after renal transplantation: A case-control study on low-dose sirolimus combined with a calcineurin inhibitor. 2015 J. Formos. Med. Assoc. pmid:25843527
Berro M et al. Allogeneic hematopoietic stem cell transplantation in the elderly. Predicting the risk for non relapse mortality. 2015 Medicina (B Aires) pmid:26339873
Robertsen I et al. Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed. 2015 Transplantation pmid:25148382
Wang L et al. Gq signaling causes glomerular injury by activating TRPC6. 2015 J. Clin. Invest. pmid:25844902
Legendre L et al. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis. 2015 J. Am. Acad. Dermatol. pmid:25840730
Manuyakorn W et al. In vitro cytokine changes after pediatric liver transplantation. 2015 Asian Pac. J. Allergy Immunol. pmid:25840634
Aouam K et al. Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase. 2015 Pharmacogenomics pmid:26615671
Eaton KV et al. Engineering macrophages to control the inflammatory response and angiogenesis. 2015 Exp. Cell Res. pmid:26610863
Tavira B et al. ABCB1 (MDR-1) pharmacogenetics of tacrolimus in renal transplanted patients: a Next Generation Sequencing approach. 2015 Clin. Chem. Lab. Med. pmid:25781547
Burke MT et al. Expression of Bcl-xL and Mcl-1 in the nonmelanoma skin cancers of renal transplant recipients. 2015 Am. J. Clin. Pathol. pmid:25780003
Plischke M et al. Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial. 2015 PLoS ONE pmid:26270340
Nouchi A et al. [Treatment of angiolymphoid hyperplasia with eosinophilia (ALHE) using topical tacrolimus: Two cases]. 2015 Ann Dermatol Venereol pmid:25778634
Chen F et al. [Outcomes of allogeneic hematopoietic stem cell transplantation for 18 patients with paroxysmal nocturnal haemoglobinuria]. 2015 Zhonghua Xue Ye Xue Za Zhi pmid:26759101
Morales E et al. A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab. 2015 Transpl. Int. pmid:25712140
Buschow SI et al. To target or not to target viral antigens in HBV related HCC? 2015 J. Hepatol. pmid:25711422
Qasim W et al. Reply to: "To target or not to target viral antigens in HBV related HCC?". 2015 J. Hepatol. pmid:25711420
Jia N et al. Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature. 2015 BMC Cancer pmid:26197890
Kawano N et al. Successful Secondary Umbilical Cord Blood Transplantation for Graft Failure in Acute Myelogenous Leukemia, Treated with Modified One-Day Conditioning Regimen, and Graft-Versus-Host Disease Prophylaxis Consisting of Mycophenolate and Tacrolimus. 2015 J Clin Exp Hematop pmid:26490521
Li ZQ et al. Efficacy and safety of tacrolimus vs. cyclophosphamide for idiopathic membranous nephropathy: A meta-analysis of Chinese adults. 2015 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:26489612
Badri P et al. Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir. 2015 Am. J. Transplant. pmid:25708713
Ayala E et al. Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma. 2015 Clin Lymphoma Myeloma Leuk pmid:25659459
Stefanović NZ et al. Potential role of tacrolimus in erythrocytes' antioxidative capacity in long-term period after renal transplantation. 2015 Eur J Pharm Sci pmid:25657088
Park JH et al. Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits. 2015 Cornea pmid:25651492
Petruzzo P et al. Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis. 2015 Ann. Surg. pmid:24646555
Polańska A et al. Monitoring of therapy in atopic dermatitis--observations with the use of high-frequency ultrasonography. 2015 Skin Res Technol pmid:24894324
Sahin G et al. Association between endothelial and platelet function markers and adiponectin in renal transplanted recipients on cyclosporine and tacrolimus immunosuppression based therapy. 2015 Nephrology (Carlton) pmid:25650527
Pérez-López I et al. Koebner phenomenon in a patient with lichen sclerosus following a jellyfish sting: an exceptional morphology. 2015 Actas Dermosifiliogr pmid:25597413
Niioka T et al. Capability of utilizing CYP3A5 polymorphisms to predict therapeutic dosage of tacrolimus at early stage post-renal transplantation. 2015 Int J Mol Sci pmid:25594874
Rojas-Vega L et al. Increased phosphorylation of the renal Na+-Cl- cotransporter in male kidney transplant recipient patients with hypertension: a prospective cohort. 2015 Am. J. Physiol. Renal Physiol. pmid:26336164
Ling Q et al. Donor PPARα Gene Polymorphisms Influence the Susceptibility to Glucose and Lipid Disorders in Liver Transplant Recipients: A Strobe-Compliant Observational Study. 2015 Medicine (Baltimore) pmid:26334901
Koch M et al. De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation. 2015 Clin Transplant pmid:26333844
Graham F et al. Tacrolimus use in renal and cardiac pediatric transplantation: no increased risk of food allergies. 2015 Ann. Allergy Asthma Immunol. pmid:26094803
Teixeira Mdo C et al. Influence of post-transplant immunosuppressive therapy on gastrointestinal transit using biomagnetic method: a pilot study. 2015 Dig. Dis. Sci. pmid:25146844
Urquhart BL and Knauer MJ Dried blood spots for therapeutic drug monitoring of tacrolimus and sirolimus in pediatric patients. 2015 Pediatr Transplant pmid:25546506
Park J et al. Iron overload triggers mitochondrial fragmentation via calcineurin-sensitive signals in HT-22 hippocampal neuron cells. 2015 Toxicology pmid:26318285
Shi RZ et al. Rapid measurement of tacrolimus in whole blood by paper spray-tandem mass spectrometry (PS-MS/MS). 2015 Clin. Chim. Acta pmid:25540885
Coilly A et al. Once-daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations. 2015 Liver Transpl. pmid:26264233
Boluda ER Pediatric small bowel transplantation. 2015 Curr Opin Organ Transplant pmid:26262456
Minami-Hori M et al. Periorbital lupus profundus successfully treated with oral tacrolimus plus low-dose prednisolone. 2015 J. Dermatol. pmid:25544984
Xing J et al. Association between interleukin-18 promoter variants and tacrolimus pharmacokinetics in Chinese renal transplant patients. 2015 Eur. J. Clin. Pharmacol. pmid:25487141
van Boekel GA et al. Delayed trough level measurement with the use of prolonged-release tacrolimus. 2015 Transpl. Int. pmid:25474192
Niioka T et al. Effects of CYP3A5 polymorphism and the tacrolimus 12 h concentration on tacrolimus-induced acute renal dysfunction in patients with lupus nephritis. 2015 Xenobiotica pmid:26189776
Gallagher HM et al. Erratic tacrolimus exposure, assessed using the standard deviation of trough blood levels, predicts chronic lung allograft dysfunction and survival. 2015 J. Heart Lung Transplant. pmid:26186804
Li Y et al. Differential regulation of Tregs and Th17/Th1 cells by a sirolimus-based regimen might be dependent on STAT-signaling in renal transplant recipients. 2015 Int. Immunopharmacol. pmid:26186486
Toole B et al. Evaluation of the New Cyclosporine and Tacrolimus Automated Electrochemiluminescence Immunoassays under Field Conditions. 2015 Clin. Lab. pmid:26554251
Shen T et al. Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation. 2015 World J. Gastroenterol. pmid:26034381
Cilião HL et al. Cytotoxic and genotoxic effects of high concentrations of the immunosuppressive drugs cyclosporine and tacrolimus in MRC-5 cells. 2015 Exp. Toxicol. Pathol. pmid:25541063
Kabrine M and Laraba-Djebari F Immunomodulatory and protective properties of tacrolimus in experimental scorpion envenomation. 2014 Jan-Mar Int J Immunopathol Pharmacol pmid:24674680
Wang C and Lin A Efficacy of topical calcineurin inhibitors in psoriasis. 2014 Jan-Feb J Cutan Med Surg pmid:24377467
Feito-Rodríguez M et al. Bacterial vaginosis in the context of lichen sclerosus in a prepubertal girl. 2014 Jan-Feb Pediatr Dermatol pmid:24125016
Veisa G et al. The importance of renal biopsy in the management of renal transplantation. 2014 Apr-Jun Rev Med Chir Soc Med Nat Iasi pmid:25076703
Kim EJ et al. Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection. 2014 Am. J. Transplant. pmid:24354871
Kamińska D et al. Significant infections after hand transplantation in a Polish population. 2014 Transplant. Proc. pmid:25380943
Venkat VL et al. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients. 2014 Liver Transpl. pmid:24634351
Kabir A Comment on: New-onset diabetes and impaired fasting glucose after a liver transplant: risk analysis and the effect of tacrolimus dosage. 2014 Exp Clin Transplant pmid:24471727
Kim H et al. Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation. 2014 Clin Mol Hepatol pmid:25320733
Shilbayeh S The impact of genetic polymorphisms on time required to attain the target tacrolimus levels and subsequent pharmacodynamic outcomes in pediatric kidney transplant patients. 2014 Saudi J Kidney Dis Transpl pmid:24625991
Sagiroglu T et al. Protective effect of everolimus on renal ischemia reperfusion injury in rats. 2014 Saudi J Kidney Dis Transpl pmid:24625994
Wang XZ et al. Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients. 2014 Transpl. Immunol. pmid:24211610
Capone F et al. Synergistic antitumor effect of Doxorubicin and tacrolimus (FK506) on hepatocellular carcinoma cell lines. 2014 ScientificWorldJournal pmid:24701168
Tischer S and Fontana RJ Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting. 2014 J. Hepatol. pmid:24280292
Arduino PG et al. Pimecrolimus vs. tacrolimus for the topical treatment of unresponsive oral erosive lichen planus: a 8 week randomized double-blind controlled study. 2014 J Eur Acad Dermatol Venereol pmid:23451852
Wasilewski G et al. Inadequate blood pressure control in orthotopic heart transplant: is there a role of kidney function and immunosuppressive regimen? 2014 Transplant. Proc. pmid:25380929
Grafals M et al. Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study. 2014 PLoS ONE pmid:25111080
Freire-Cobo C et al. The calcineurin inhibitor Ascomicin interferes with the early stage of the epileptogenic process induced by Latrunculin A microperfusion in rat hippocampus. 2014 J Neuroimmune Pharmacol pmid:25104570
Bica L et al. Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation. 2014 PLoS ONE pmid:24587210
Bergmann TK et al. Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose. 2014 Ther Drug Monit pmid:24089074
Aelvoet SA et al. Noninvasive bioluminescence imaging of α-synuclein oligomerization in mouse brain using split firefly luciferase reporters. 2014 J. Neurosci. pmid:25471588
Klintmalm GB et al. Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. 2014 Am. J. Transplant. pmid:25041339
Ikeuchi H et al. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis. 2014 Mod Rheumatol pmid:24252014
Zhao J et al. FK506-loaded chitosan conduit promotes the regeneration of injured sciatic nerves in the rat through the upregulation of brain-derived neurotrophic factor and TrkB. 2014 J. Neurol. Sci. pmid:24954089
Sureshkumar KK and Chopra B In search of an optimal induction agent in kidney transplantation. 2014 Transplantation pmid:24978038
Hacker C et al. Falsely elevated cyclosporin and tacrolimus concentrations over prolonged periods of time due to reversible adsorption to central venous catheters. 2014 Clin. Chim. Acta pmid:24631133
Hallowell RW and Danoff SK Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances. 2014 Curr Opin Rheumatol pmid:25203119
Lalan S et al. Effect of CYP3A5 genotype, steroids, and azoles on tacrolimus in a pediatric renal transplant population. 2014 Pediatr. Nephrol. pmid:24875272
Ricardo E et al. In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei. 2014 Antimicrob. Agents Chemother. pmid:24867987
Agrawal YP et al. Transplant patient classification and tacrolimus assays: more evidence of the need for assay standardization. 2014 Ther Drug Monit pmid:24784024
Mitsides N et al. Dapsone-induced methemoglobinemia in renal transplant recipients: more prevalent than previously thought. 2014 Transpl Infect Dis pmid:24215452
Nair S and Waters B Telaprevir in treatment of recurrent hepatitis C infection in liver transplant recipients. 2014 Exp Clin Transplant pmid:24702143
Navas-López VM et al. Successful treatment for ulcerative proctitis with rectal tacrolimus in an 8-year-old girl with intolerance to mesalamine. 2014 Clin J Gastroenterol pmid:26185880